Effect of Preoperative Hemoglobin A1c on Bariatric Surgery Outcomes

      Bariatric or metabolic surgery is increasingly used as an adjunct to the treatment of diabetes. Many studies have demonstrated surgery to be superior to medical management. However, many programs require that patients meet a target hemoglobin A1c (Hgb A1c) level. As a result, some patients are denied surgery due to an inability to achieve an arbitrary Hgb A1c level. We sought to understand the impact of preoperative A1c levels on perioperative outcomes, including diabetes resolution and weight loss.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect